High concentration antibody-containing liquid formulation
US11008394B2 · kind B2 · utility
4Cited by
64References
16Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Apr 22, 2019 |
| Grant date | May 18, 2021 |
| Priority date | — |
| Expiry date | Apr 22, 2039 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07K2317/76
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The problem to be solved is to provide an antibody-containing formulation which is stable and suited for subcutaneous administration, wherein dimerization and deamidation is prevented during long-term storage. The present application is directed to a stable antibody-containing liquid formulation characterized by containing arginine and methionine.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.